Description:

Southwest Oncology Group Registration Form - Step #3 NCT00492856 Combination Chemotherapy With or Without Gemtuzumab Followed By Tretinoin, Mercaptopurine, and Methotrexate or Observation in Treating Patients With Acute Promyelocytic Leukemia Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=01E95CDA-068E-07BB-E044-0003BA3F9857

Link:

https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=01E95CDA-068E-07BB-E044-0003BA3F9857

Keywords:
Versions (4) ▾
  1. 9/19/12
  2. 1/9/15
  3. 1/9/15
  4. 6/27/15
Uploaded on:

June 27, 2015

DOI:
No DOI assigned. To request one please log in.
License:
Creative Commons BY-NC 3.0 Legacy
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

Southwest Oncology Group Registration Form - Step #3 NCT00492856

No Instruction available.

  1. StudyEvent: Southwest Oncology Group Registration Form - Step #3
    1. No Instruction available.
SWOG clinical trial administrative data
Patient demographics
Stratification Factors
Age at first registration
APL risk group
Did patient receive consolidation cycle 3 or 4 (ATRA plus Daunorubicin)

Similar models